Other

Merck beats 1Q profit views with tight cost controls

Merck posted an 18 percent jump in first-quarter income, beating Wall Street expectations, as reduced spending on marketing, administration and research easily offset lower medicine sales outside the U.S.

Other

UK probes mega AstraZeneca deal for US biotech firm

Britain's competition watchdog on Tuesday said it was investigating the planned purchase of US biotech company Alexion by COVID vaccine-maker AstraZeneca in a deal worth $39 billion.

Medical economics

Lax antitrust enforcement linked to rising hospital prices

A new study co-authored by a Yale economist provides evidence that insufficient antitrust enforcement in the U.S. hospital sector is contributing to reduced competition and higher prices for hospital care.

Medications

Improving competition and reducing costs of bio-pharmaceuticals

Georgia State Law associate professor Yaniv Heled focuses his career on the intersection of biotechnology and the law. For nearly a decade, he has dedicated much of his research to the regulation of bio-pharmaceuticals (also ...

Pediatrics

Sporting tips for parents and preschoolers

Parents should think twice before putting preschoolers into competitive sporting programs, say Flinders University experts who are concerned about sport participation levels throughout school years to young adulthood.

Other

Sanofi earnings slashed in first quarter

(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.

page 15 from 17